Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial

• Egile Nagusiak: Yan Gong (Egilea), Kun Zhang (Egilea), Dongsheng Xiong (Egilea), Jiajing Wei (Egilea), Hao Tan (Egilea), Shengfang Qin (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2020-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Oxidative stress (OS), defined as an imbalance between excessive reactive oxygen species (ROS) and/or reactive nitrogen species (RNS) production and antioxidant insufficiency, has been suggested to be involved in the pathogenesis of poor ovarian response (POR). Growth hormone (GH...